Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Theresa Gruber"'
Autor:
Ratchaneewan Khiaosa-ard, Matteo Ottoboni, Stefanie Verstringe, Theresa Gruber, Thomas Hartinger, Elke Humer, Geert Bruggeman, Qendrim Zebeli
Publikováno v:
Journal of Dairy Science, Vol 106, Iss 12, Pp 8758-8773 (2023)
ABSTRACT: Supplemental Mg sources differ in bioavailability, and solubility is one of the determining factors. We explored whether and which in vitro solubility tests could reliably differentiate the quality of supplemental Mg sources. In experiment
Externí odkaz:
https://doaj.org/article/c3386c7a6cfe4c3d9b96b6fb0239e357
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0232764 (2020)
OBJECTIVE:This study aimed to explore the association between malnutrition, clinical parameters, and health-related quality of life in elderly hospitalized patients with Parkinson's disease (PD). METHODS:Cross-sectional study of 92 hospitalized elder
Externí odkaz:
https://doaj.org/article/39d6c22dba764ea8a83702b4149b4815
Publikováno v:
Journal of the American Animal Hospital Association. 55:23-28
Twenty-five cats at a private animal sanctuary received multiple nonimmunosuppressive doses of parenteral methylprednisolone acetate for at least 3 yr. Complete blood count, chemistry, and T4 results from these cats were examined to look for statisti
Publikováno v:
American Journal of Hematology. 90:561-563
Autor:
Reza Jahan, Theresa Gruber, Aleš Blinc, Gregor Tratar, Victor J. Marder, Gary Duckwiler, Doojin Kim, David S Liebeskind, Paul M. Vespa, Sidney Starkman, Fernando Vinuela, Bruce Ovbiagele, Satoshi Tateshima, Jeffrey L. Saver, Nestor R Gonzalez, Mišo Šabovič, Letisha Ali
Publikováno v:
Stroke. 42:2222-2228
Background and Purpose— Plasmin is a direct-acting thrombolytic with a better safety profile than recombinant tissue-type plasminogen activator (rtPA) in animal models. With the application of retrieval devices for managing acute ischemic stroke, e
Autor:
Theresa Gruber, Herbert J. Meiselman, Fabrizia Urbinati, Donald B. Kohn, Sally Shupien, Michael L. Kaufman, Mark C. Walters, Alyse Gellis, Rosalinda B. Wenby, Satiro deOliveira, Shantha Senadheera, David W. Gjertson, Xiangyang Jin, Thomas D. Coates, Zulema Romero, Aaron R. Cooper, Roger P. Hollis, Victor J. Marder, Hisham Abdel-Azim, Rafael Ruiz de Assin, Sabine Geiger, Arineh Sahagian, Pamela Kempert, Jennifer Wherley, Xiaoyan Wang
Publikováno v:
The Journal of clinical investigation.
Autologous hematopoietic stem cell gene therapy is an approach to treating sickle cell disease (SCD) patients that may result in lower morbidity than allogeneic transplantation. We examined the potential of a lentiviral vector (LV) (CCL-βAS3-FB) enc
Autor:
Theresa Gruber, Tony Mosconi
Publikováno v:
Somatosensorymotor research. 27(4)
To establish the mouse mutant, hairless (Hr), as a useful model for future analyses of target-ending interactions, we assessed the cutaneous innervation in the whisker pad after loss of primary hair targets. Postnatal (P) development of fur in Hr beg
Publikováno v:
Stroke. 41
Plasmin is a direct-acting thrombolytic agent with a striking hemostatic safety advantage over plasminogen activators in animal models of thrombolysis and bleeding. In contradistinction to plasminogen activators, which risk bleeding at any effective
Autor:
Theresa Gruber, Jennifer L. Hunt, Steve Manyak, Philip Scuderi, Guillermo Moreno, Victor J. Marder, Valery Novokhatny, Abha Goyal, John Bromirski, Stephen R. Petteway
Publikováno v:
Thrombosis and haemostasis. 104(4)
SummaryWe previously demonstrated a significant margin of haemostatic safety for full-length plasmin in comparison with tissue plasminogen activator (t-PA). We now report studies that compare haemostatic safety of full-length plasmin with a novel rec
Autor:
Theresa Gruber, Philip Scuderi, Victor J. Marder, Steve Petteway, Valery Novokhatny, Jennifer A. Hunt, John Bromirski, Steve Manyak, Abha Goyal
Publikováno v:
Blood. 112:2028-2028
Background: All thrombolytic agents in current clinical use are plasminogen activators (PA). While effective, PA have a downside because of unavoidable and potentially lifethreatening bleeding complications in vulnerable patients. We previously demon